Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
600
-
Shares change
-
+600
-
Total reported value, excl. options
-
$493K
-
Value change
-
+$493K
-
Number of buys
-
1
-
Price
-
$821.67
Significant Holders of REGENERON PHARMACEUTICALS - COM - Call as of Q1 2023
11 filings reported holding 75886F907 - REGENERON PHARMACEUTICALS - COM - Call as of Q1 2023.
REGENERON PHARMACEUTICALS - COM - Call has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 600 shares
.
Largest 10 shareholders include HRT FINANCIAL LP (600 shares), JPMORGAN CHASE & CO (170K shares), GROUP ONE TRADING, L.P. (118K shares), SIMPLEX TRADING, LLC (54.7K shares), JANE STREET GROUP, LLC (47.5K shares), IMC-Chicago, LLC (24.9K shares), SG Americas Securities, LLC (18.7K shares), Allianz Asset Management GmbH (10.2K shares), Twin Tree Management, LP (3.4K shares), and GARDA CAPITAL PARTNERS LP (1.5K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.